Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

Unlimited Transportation Passes for Unstable Housed People Living With HIV Trial

ClinicalTrials.gov ID: NCT06483152

Public ClinicalTrials.gov record NCT06483152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 9, 2026, 12:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Getting to Zero: Resolving Transportation Barriers to Participation in Services Among Unstably Housed PLWH

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this trial is to learn if providing an unlimited transit pass will improve the health of people living with HIV that are experiencing unstable housing. The main questions it aims to answer are: 1. Do participants who are provided the transit pass manage their HIV better? 2. Do participants who are provided the transit pass use other social services more that could improve their health and quality of life? Researchers will compare the group that is provided with the transit pass to a control group that is not provided with the pass. Participants will fill out a baseline survey and a follow-up survey after 6 months. Researchers will also look at participant's HIV lab tests to see how well their HIV is being managed.

Study identification

NCT ID
NCT06483152
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
The Aliveness Project
Other
Enrollment
146 participants

Conditions and interventions

Conditions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2024
Primary completion
Jan 31, 2025
Completion
Jan 31, 2025
Last update posted
Jul 2, 2024

2024 – 2025

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
The Aliveness Project Minneapolis Minnesota 55409

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06483152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2024 · Synced Sep 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06483152 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →